Plasma cell predominant B cell pseudolymphoma

Stephen J. Nervi; R. A. Schwartz

Plasma cell predominant B cell pseudolymphoma

Research output: Contribution to journal › Article › peer-review

Abstract

A 46-year-old woman with no history of foreign travel presented to the New Jersey Medical School Dermatology Clinic in July, 2007, with pruritic ulcerating facial masses that had been present since October, 2006. Clinical and histopathologic findings were most consistent with a diagnosis of cutaneous plasma cell predominant B cell pseudolymphoma. An extensive search using special stains for an etiologic organism was negative. The term cutaneous pseudolymphoma has been coined to describe the accumulation of either T or B cell lymphocytes in the skin that is caused by a nonmalignant stimulus and encompasses several different terms depending on etiology. In cases of cutaneous pseudolymphoma where a cause is identified, treatment entails removing the underlying causative agent. Idiopathic cases tend to be recalcitrant to treatment.

Original language	American English
Article number	12
Journal	Dermatology Online Journal
Volume	14
Issue number	10
State	Published - Oct 2008
Externally published	Yes

ASJC Scopus subject areas

Dermatology

Cite this

@article{6f41e35f776e44f498fe1300887d638e,

title = "Plasma cell predominant B cell pseudolymphoma",

abstract = "A 46-year-old woman with no history of foreign travel presented to the New Jersey Medical School Dermatology Clinic in July, 2007, with pruritic ulcerating facial masses that had been present since October, 2006. Clinical and histopathologic findings were most consistent with a diagnosis of cutaneous plasma cell predominant B cell pseudolymphoma. An extensive search using special stains for an etiologic organism was negative. The term cutaneous pseudolymphoma has been coined to describe the accumulation of either T or B cell lymphocytes in the skin that is caused by a nonmalignant stimulus and encompasses several different terms depending on etiology. In cases of cutaneous pseudolymphoma where a cause is identified, treatment entails removing the underlying causative agent. Idiopathic cases tend to be recalcitrant to treatment.",

author = "Nervi, {Stephen J.} and Schwartz, {R. A.}",

year = "2008",

month = oct,

language = "American English",

volume = "14",

journal = "Dermatology Online Journal",

issn = "1087-2108",

publisher = "Department of Dermatology UC Davis",

number = "10",

}

TY - JOUR

T1 - Plasma cell predominant B cell pseudolymphoma

AU - Nervi, Stephen J.

AU - Schwartz, R. A.

PY - 2008/10

Y1 - 2008/10

N2 - A 46-year-old woman with no history of foreign travel presented to the New Jersey Medical School Dermatology Clinic in July, 2007, with pruritic ulcerating facial masses that had been present since October, 2006. Clinical and histopathologic findings were most consistent with a diagnosis of cutaneous plasma cell predominant B cell pseudolymphoma. An extensive search using special stains for an etiologic organism was negative. The term cutaneous pseudolymphoma has been coined to describe the accumulation of either T or B cell lymphocytes in the skin that is caused by a nonmalignant stimulus and encompasses several different terms depending on etiology. In cases of cutaneous pseudolymphoma where a cause is identified, treatment entails removing the underlying causative agent. Idiopathic cases tend to be recalcitrant to treatment.

AB - A 46-year-old woman with no history of foreign travel presented to the New Jersey Medical School Dermatology Clinic in July, 2007, with pruritic ulcerating facial masses that had been present since October, 2006. Clinical and histopathologic findings were most consistent with a diagnosis of cutaneous plasma cell predominant B cell pseudolymphoma. An extensive search using special stains for an etiologic organism was negative. The term cutaneous pseudolymphoma has been coined to describe the accumulation of either T or B cell lymphocytes in the skin that is caused by a nonmalignant stimulus and encompasses several different terms depending on etiology. In cases of cutaneous pseudolymphoma where a cause is identified, treatment entails removing the underlying causative agent. Idiopathic cases tend to be recalcitrant to treatment.

UR - http://www.scopus.com/inward/record.url?scp=55249109516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249109516&partnerID=8YFLogxK

M3 - Article

C2 - 19061611

SN - 1087-2108

VL - 14

JO - Dermatology Online Journal

JF - Dermatology Online Journal

IS - 10

M1 - 12

ER -

Plasma cell predominant B cell pseudolymphoma

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this